Beta Bionics (BBNX) Long-Term Investments (2025 - 2026)
Beta Bionics (BBNX) posted Long-Term Investments of $44.6 million for Q2 2026, up 12.0% sequentially from $39.9 million in Q1 2026, and up 43.34% YoY from $31.1 million in Q2 2025.
Beta Bionics (BBNX) Long-Term Investments (2025 - 2026) Analysis & Trends
Beta Bionics has reported Long-Term Investments for 2 years, with the latest figure at $44.6 million in Q2 2026.
- Quarterly Long-Term Investments rose 43.34% year-over-year to $44.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $44.6 million (up 43.34% YoY) and the FY2025 annual result came in at $45.4 million, changed N/A from the prior year.
- Long-Term Investments climbed to $44.6 million in Q2 2026 per BBNX's latest filing, from $39.9 million in the prior quarter.
- Over five years, Long-Term Investments peaked at $64.0 million in Q1 2025 and troughed at $31.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 1.11 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 2.25 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 244.10 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 175.52 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | Beta Bionics | 865.29 Mn | 684.80 Mn | 18.90 Mn | 44.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 44.65 Mn |
| Mar 31, 2026 | 39.87 Mn |
| Dec 31, 2025 | 45.43 Mn |
| Sep 30, 2025 | 45.33 Mn |
| Jun 30, 2025 | 31.15 Mn |
| Mar 31, 2025 | 64.00 Mn |